Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vasopressin on Attention Control
NCT06329037Recruiting
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Mar 2024
- Primary completion
- Jun 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Vasopressin group with Placebo group (2 arms). Primary endpoints: Saccade/antisaccade latency difference between social and non-social stimuli and Error rate of saccade/antisaccade for social versus non-social stimuli. Started Mar 2024; status: recruiting.
02
Drugs
vasopressin
Beyond the preview
Go deeper on NCT06329037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06329037.